Palisade Bio News and Activities

Palisade Bio is a company listed under the stock ticker PALI (US).

View the org chart displaying its 15 main executives

Most searched biographies at Palisade Bio

• JD Finley, Chief Executive Officer and Director
• Robert Baltera, Director
• Binxian Wei, Director

Popular executive movements at Palisade Bio

• Jordan Zwick has joined the company as Director  (posted on June 11 2026).
• Robert Baltera has joined the company as Director  (posted on June 11 2026).
• James Izanec has joined the company as Vice President, Clinical Development  (posted on December 2 2025).

Click here to view some more movements at Palisade Bio

Create your alert
to follow the executive moves at Palisade Bio.

Palisade Bio has 2,424 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).
• BridgeBio has just announced a $1,000 Million fundraising (posted on July 2 2026).
• Flare Therapeutics has just announced a $85 Million fundraising (posted on July 2 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Palisade Bio

• Palisade Bio Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could be Utilized as a Potential Marker for Patient Stratification - Palisade Bio
• Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Palisade Bio
• Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business Update - Palisade Bio
• Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis - Palisade Bio
• Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactivation of Lead Product Candidate, PALI-2108 - Palisade Bio
• Palisade Bio Participates in Virtual Investor "What this Means" Segment - Palisade Bio
• Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108 - Palisade Bio
• Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product - Palisade Bio
• Palisade Bio to Participate in the Virtual Investor Closing Bell Series - Palisade Bio
• Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences - Palisade Bio
• View more press releases Close

Social media about Palisade Bio

• Palisade Bio on Wikipedia, Google News & Yahoo Finance
• Palisade Bio on LinkedIn, X (Twitter) & YouTube